FDA Inspection 1217533 — ARK-LA-TEX Fertility and Reproductive Medicine, PMC

ARK-LA-TEX Fertility and Reproductive Medicine, PMC — FEI 3010600107

The FDA completed an inspection of ARK-LA-TEX Fertility and Reproductive Medicine, PMC on August 23, 2023 in Shreveport, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 23, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Shreveport, LA (United States)